We also calculated the activity score of ERG in a separate cohort of lung cancer patients from TCGA and similarly used it for patient stratification, obtaining a P-value of 0.067 in the Kaplan–Meier analysis (Supplementary Fig. S6). This evidence concerns the gene ERG and lung carcinoma.